Research groups
Colleges
Websites
-
Oxford Parkinson's Disease Centre
Group Leader
-
International Society for Monitoring Molecules
President
-
Dopamine Society
Inaugural Officer
-
International Basal Ganglia Society
Member of Council
-
ACS Chemical Neuroscience
Editorial Advisory Board
-
Addiction Neuroscience
Editorial Board
-
npj Parkinson's Disease
Editorial Board
LAB FUNDING
We are grateful for support from
- Aligning Science Across Parkinson's and the Michael J. Fox Foundation
- Biotechnology and Biological Sciences Resarch Council
- Christ Church College
- Medical Research Council
- Parkinson's UK
- Wellcome
Stephanie Cragg
MA DPhil
Professor of Neuroscience
My laboratory focuses on understanding dopamine neurotransmission in the brain, particularly within the basal ganglia. We seek to improve understanding of the mechanisms regulating dopamine transmission and their dysfunction in neurodegenerative and other brain disorders, particularly Parkinson's disease and addictions, to gain insights into disease aetiology and therapeutic avenues. We are a founding group of the Oxford Parkinson's Disease Centre (OPDC).
I studied Natural Sciences at the University of Cambridge, followed by a DPhil at the University of Oxford Department of Pharmacology as a Mary Goodger Scholar. I was awarded postdoctoral E.P. Abraham Junior Research Fellowships from Keble College and then St. Cross College Oxford, followed by a Beit Memorial Prize Fellowship, and a Paton Research Fellowship at the University Department of Pharmacology, Oxford. My Fellowships involved stints at New York University Departments of Physiology & Biophysics and Neurosurgery, with Drs Margaret Rice and Charles Nicholson, and in the lab of Dr R. Mark Wightman at the University of North Carolina Department of Chemistry. I joined the Department of Physiology, Anatomy and Genetics in Oxford in 2006 through a joint appointment as University Lecturer and Tutor for Medicine at the college Christ Church. In 2014, I became Professor of Neuroscience.
I am current President of the International Society for Monitoring Molecules in Neuroscience, co-founder of the inaugural Dopamine Society, Member of Council for the International Basal Ganglia Society, and serve on the Editorial Advisory Board for ACS Chemical Neuroscience, and on the inaugural Editorial Boards for Addiction Neuroscience and npj Parkinson's Disease. I have previously served stints in Parkinson's UK College of Experts, as Associate Editor at npj Parkinson's Disease, and as Chair of the 17th International Conference on Monitoring Molecules in Neuroscience held in 2018. I am co-Editor with colleague Prof Mark Walton of The Handbook of Dopamine, a new defining volume in the field published in August 2025.
Group News
Please see the Cragg Team Webpage for news and current recruitment opportunities!
Recent publications
Dopamine release from Parkinson’s patient-derived neurons is disrupted due to impaired synaptic vesicle loading
Preprint
Cramb KML. et al, (2026)
Corrigendum to "New insights into axonal regulators of dopamine transmission in health and disease" [Curr Op Neurobiol 94 (2025) 103093].
Journal article
Todd KL. et al, (2026), Curr Opin Neurobiol, 96
An anatomical hotspot for striatal dopamine-acetylcholine interactions during reward and movement.
Journal article
Bouabid S. et al, (2026), bioRxiv
Adenosine in the Brain: Recent Progress on Detection, Function, and Translation.
Journal article
Yahiro T. et al, (2025), J Neurosci, 45
The trace amine-associated receptor 1 regulates presynaptic dopamine function: evidence from preclinical studies and a phase 1b trial in patients with schizophrenia.
Journal article
Howes OD. et al, (2025), Biol Psychiatry
New insights into axonal regulators of dopamine transmission in health and disease.
Journal article
Todd KL. et al, (2025), Curr Opin Neurobiol, 94
Gabapentinoids promote striatal dopamine release and rescue multiple deficits of a mouse model of early Parkinson’s
Preprint
Brimblecombe KR. et al, (2025)

